Suppr超能文献

颗粒漂流效应对肠道非搅动水层有效厚度的可能降低作用。

Possible reduction of effective thickness of intestinal unstirred water layer by particle drifting effect.

机构信息

Global Research & Development, Sandwich Laboratories, Research Formulation, Pfizer Inc., CT13 9NJ, Sandwich, Kent, UK.

出版信息

Int J Pharm. 2010 Mar 15;387(1-2):103-9. doi: 10.1016/j.ijpharm.2009.12.014. Epub 2009 Dec 16.

Abstract

According to the present theory of oral absorption, in the case of solubility limited absorption, the absorbed amount would not increase despite an increase in dose or a decrease in particle size. However, many experimental observations suggested that the absorbed amount was often increased (though sub-proportionally) as the dose strength increased. In addition, the particle size reduction was often effective to increase the absorbed amount even in the case of solubility limited absorption. Since an increase of the dose strength and a decrease of the particle size cause no or little change in solubility and the mean intestinal transit time, effective intestinal membrane permeability (P(eff)) should have changed. The previous theory postulated that drug particles do not exist in the unstirred water layer (UWL) which is adjacent to the intestinal membrane. However, many reports suggested that nano- to micro-scale drug particles existed in the UWL. In this case, the effective thickness of the UWL (h(eff)) could be smaller than the nominal thickness, resulting in an increase of P(eff). In the present study, h(eff) was simply calculated assuming that the reduction of h(eff) is in proportion to the surface area of drug particles in the UWL. When the particle drifting effect was taken into account, the discrepancy between the theoretical calculation and experimental observations was reduced. It was suggested that when the dose (mg)/particle diameter (microm) ratio exceeds 20, the particle drifting effect would become significant.

摘要

根据目前的口服吸收理论,在溶解度限制吸收的情况下,尽管增加剂量或减小粒径,吸收量也不会增加。然而,许多实验观察表明,尽管不成比例,但随着剂量强度的增加,吸收量通常会增加。此外,即使在溶解度限制吸收的情况下,减小粒径通常也能有效地增加吸收量。由于增加剂量强度和减小粒径对溶解度和平均肠道转运时间几乎没有或没有影响,因此有效肠膜通透性(P(eff))应该发生了变化。之前的理论假设药物粒子不存在于与肠膜相邻的未搅动水层(UWL)中。然而,许多报告表明纳米到微米级的药物粒子存在于 UWL 中。在这种情况下,UWL 的有效厚度(h(eff))可能小于名义厚度,从而导致 P(eff)增加。在本研究中,假设 h(eff)的减小与 UWL 中药物粒子的表面积成比例,从而简单地计算了 h(eff)。当考虑到粒子漂移效应时,理论计算与实验观察之间的差异减小了。当剂量(mg)/粒径(μm)比超过 20 时,建议粒子漂移效应变得显著。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验